| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40,0 k € | +34.4% | 29,8 k € | +91.7% | 15,5 k € | -29.6% | 22,1 k € | -14.3% | 25,7 k € | -18.3% | 31,5 k € | 0.0% | 31,5 k € | 0.0% | 31,5 k € | 0.0% | 31,5 k € | -39.2% | 51,9 k € | +24.7% | 41,6 k € | -19.6% | 51,8 k € | -7.4% | 55,9 k € | +11.4% | 50,2 k € | +9.4% | 45,9 k € | -23.8% | 60,2 k € | -22.4% | 77,6 k € | -1.4% | 78,6 k € | -1.3% | 79,7 k € | |
| EBITDA | 579,1 k € | +16877.7% | 3,4 k € | -91.2% | 39,0 k € | +132.0% | 16,8 k € | -21.1% | 21,3 k € | -21.3% | 27,0 k € | -1.2% | 27,4 k € | -90.3% | 280,9 k € | +248.6% | 80,6 k € | -23.4% | 105,1 k € | -10.0% | 116,8 k € | +15.0% | 101,6 k € | -1.1% | 102,7 k € | +6.2% | 96,8 k € | +4.8% | 92,3 k € | -14.1% | 107,5 k € | -13.4% | 124,1 k € | -70.6% | 422,6 k € | +240.4% | -300,9 k € | |
| Operating profit | 579,1 k € | +16877.7% | 3,4 k € | -91.2% | 39,0 k € | +123.3% | -167,6 k € | -887.1% | 21,3 k € | +6.2% | 20,1 k € | +18.8% | 16,9 k € | -93.8% | 270,4 k € | +1214.4% | 20,6 k € | -26.5% | 28,0 k € | +329.0% | -12,2 k € | -139.8% | 30,7 k € | -32.1% | 45,2 k € | +15.2% | 39,3 k € | +12.7% | 34,9 k € | -38.8% | 57,0 k € | -26.1% | 77,0 k € | -79.7% | 379,1 k € | +210.0% | -344,7 k € | |
| Profit/loss | 608,6 k € | +2408.6% | 24,3 k € | -39.6% | 40,2 k € | +129.3% | -137,1 k € | -178.3% | 175,0 k € | +737.4% | 20,9 k € | +13.3% | 18,4 k € | -92.3% | 240,8 k € | +667.7% | 31,4 k € | -85.7% | 219,5 k € | +1120.1% | -21,5 k € | -130.5% | 70,5 k € | +33.6% | 52,8 k € | +275.8% | 14,0 k € | +5216.4% | 264,0 € | -36.2% | 414,0 € | +110.0% | -4,1 k € | -110.0% | 41,5 k € | +27.9% | 32,5 k € | |
| Equity | 2,0 M € | +44.3% | 1,4 M € | +1.8% | 1,3 M € | +3.1% | 1,3 M € | -9.5% | 1,4 M € | +13.8% | 1,3 M € | +1.7% | 1,3 M € | +1.5% | 1,2 M € | +24.3% | 990,9 k € | +3.3% | 959,5 k € | +29.7% | 740,0 k € | -2.8% | 761,5 k € | +10.2% | 691,1 k € | +268.1% | 187,7 k € | +8.1% | 173,7 k € | +0.2% | 173,4 k € | +0.2% | 173,0 k € | -2.3% | 177,2 k € | +30.6% | 135,7 k € | |
| Total assets | 2,0 M € | +44.2% | 1,4 M € | +1.9% | 1,4 M € | +3.5% | 1,3 M € | -20.0% | 1,6 M € | -18.5% | 2,0 M € | -2.7% | 2,1 M € | -31.2% | 3,0 M € | +10.5% | 2,7 M € | -28.3% | 3,8 M € | +1.1% | 3,8 M € | +5.4% | 3,6 M € | -4.1% | 3,7 M € | +11.6% | 3,3 M € | +35.2% | 2,5 M € | -10.1% | 2,7 M € | -43.2% | 4,8 M € | -38.3% | 7,8 M € | +28.0% | 6,1 M € | |
| Cash | — | — | — | — | 31,8 k € | +349.1% | 7,1 k € | -34.0% | 10,7 k € | -98.0% | 532,6 k € | +2401.7% | 21,3 k € | -76.7% | 91,6 k € | -71.0% | 316,1 k € | +3471.6% | 8,8 k € | -74.8% | 35,2 k € | +576.1% | 5,2 k € | -60.6% | 13,2 k € | +105.2% | 6,4 k € | +182.1% | 2,3 k € | -99.4% | 354,5 k € | +983.2% | 32,7 k € | |||||
| Debts | 14,5 k € | +42.0% | 10,2 k € | +24.3% | 8,2 k € | +167.9% | 3,1 k € | -98.4% | 186,0 k € | -74.5% | 729,7 k € | -10.9% | 819,3 k € | -53.2% | 1,8 M € | +1.2% | 1,7 M € | -38.4% | 2,8 M € | -5.4% | 3,0 M € | +5.9% | 2,8 M € | -6.0% | 3,0 M € | -5.1% | 3,1 M € | +37.2% | 2,3 M € | -10.8% | 2,6 M € | -44.9% | 4,7 M € | -39.2% | 7,6 M € | +36.1% | 5,6 M € | |
Private limited company · Sint-Niklaas · incorporated on 23/12/2002
Private limited company profitable and well capitalised. Cash position rising (+349.1%).
Solid counterparty for a standard engagement.
FEBELFARMA is a Private limited company incorporated in 2002. Its main activity is: Management consultancy activities. Its registered office is in Sint-Niklaas.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette